Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Valeant Pharmaceuticals International Inc

+ Add to Watchlist

VRX:US

159.9700 USD 1.5400 0.95%

As of 20:04:05 ET on 01/30/2015.

Snapshot for Valeant Pharmaceuticals International Inc (VRX)

Open: 160.2400 Day's Range: 158.3500 - 161.7300 Volume: 1,409,813
Previous Close: 161.5100 52wk Range: 106.0000 - 162.8000 1-Yr Rtn: +17.94%

Stock Chart for VRX

No chart data available.
  • VRX:US 159.9700
  • 1D
  • 1M
  • 1Y
161.5100
Interactive VRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VRX

Current P/E Ratio (ttm) 64.6053
Estimated P/E(12/2014) 19.2642
Relative P/E vs. SPX 2.6729
Earnings Per Share (USD) (ttm) 2.4761
Est. EPS (USD) (12/2014) 8.3040
Est. PEG Ratio 1.1746
Market Cap (M USD) 53,361.54
Shares Outstanding (M) 333.57
30 Day Average Volume 2,046,305
Price/Book (mrq) 10.4302
Price/Sale (ttm) 6.6596
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.0000
Dividend Ex-Date 11/10/2010
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VRX

Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.

Laizer D KornwasserChairman/Exec VPJ Michael Pearson "Mike"Chief Executive Officer
Pavel MirovskyPresident/Gen Mgr:EuropeHoward B SchillerExec VP/CFO
More Company Profile & Key Executives for VRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil